Minnow Street Minnow Street
Buy Day today: Poor Neutral (49) Good Mixed market breadth · no major macro event

Centene Corp (CNC)

Healthcare Healthcare Plans
65.80 $
Closing price · As of: 20. Jul 2026
🔔 Watch stock

Appears in These Scanners

This stock currently matches 21 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Basics

Market Cap
32.0Mrd. $
Shares Outstanding
494Mio.
Float
92.9%
Beta
1.1

Performance

Perf. 1M
9.60%
Perf. 3M
101.70%
Perf. 6M
61.80%
YTD Performance (%)
53.40%
52-Week-High Distance
-2.7%

Valuation

P/E
Forward P/E
19.6
PEG
1.3
P/B
1.5
P/S
0.2
EV/EBITDA
3.8
Price/FCF
5.0

Profitability

Gross Margin
10.6%
EBIT Margin
5.1%
Net Margin
-3.6%
Return on Equity
-26.0%
Return on Assets
1.2%

Balance Sheet & Safety

Equity Ratio
26.4%
Debt/Equity
1.5
Altman Z
3.96
very solid
Piotroski
9 von 9

Growth

Sales Growth Last Quarter
5.10%
EPS Growth Last Quarter
18.30%
Sales Growth (Year)
19.44%
Forward Sales Growth
0.38%
Forward EPS Growth
26.70%

Quality & Screener

Stage
2
Top 10%
RS Rating
90
EPS Rating
64
very solid
Piotroski
9 von 9
Fundamental Rating
C (+5 von 100)
Altman Z
3.96

AI Rating

Uses AI

Centene setzt laut Geschäftsbericht (10-K) 2025 künstliche Intelligenz, Machine Learning und prädiktive Modelle operativ ein, um Kosten zu senken, den Zugang zu wertorientierter Versorgung zu verbessern und die betriebliche Effizienz zu steigern (u. a. Verwaltung, Betrugserkennung, Versorgungssteuerung). KI ist keine eigene Umsatzquelle; die Risikofaktoren nennen KI zudem als Compliance-, Regulierungs- und Sicherheitsrisiko fürs eigene Geschäft. Nach der Vorrangregel überwiegt der belegte operative Einsatz — Einstufung „Nutzt KI".

View the full file — quotes, sources, reviewed filings
„In connection with these initiatives, we have utilized artificial intelligence (AI), Machine Learning (ML), and predictive modeling in ways that lower costs, advance access to value-based care and increase operational efficiencies for each of our employees, members, vendors and provider partners."

Im Zusammenhang mit diesen Initiativen haben wir künstliche Intelligenz (KI), Machine Learning (ML) und prädiktive Modellierung so eingesetzt, dass sie Kosten senken, den Zugang zu wertorientierter Versorgung verbessern und die betriebliche Effizienz für jeden unserer Mitarbeiter, Mitglieder, Lieferanten und Leistungspartner erhöhen.

10-K · 2026-02-17 · View SEC filing
„We increasingly rely on new and evolving technologies, including those powered by or incorporating artificial intelligence, as part of our internal operations and in the delivery of our products and services."

Wir verlassen uns zunehmend auf neue und sich weiterentwickelnde Technologien, einschließlich solcher, die auf künstlicher Intelligenz beruhen oder diese enthalten, als Teil unseres internen Betriebs und bei der Bereitstellung unserer Produkte und Dienstleistungen.

10-K · 2026-02-17 · View SEC filing

Rated on July 10, 2026 · How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Sales Per Quarter ($M)
2024: Q4 · 40,805.0 Mio. $ Q4 2025: Q1 · 46,620.0 Mio. $ Q1 2025: Q2 · 48,742.0 Mio. $ Q2 2025: Q3 · 49,690.0 Mio. $ Q3 2025: Q4 · 49,725.0 Mio. $ Q4 2026: Q1 · 49,944.0 Mio. $ Q1
Earnings Per Share Per Quarter ($)
2024: Q4 · 0.56 $ Q4 2025: Q1 · 2.63 $ Q1 2025: Q2 · -0.51 $ Q2 2025: Q3 · -13.50 $ Q3 2025: Q4 · -2.24 $ Q4 2026: Q1 · 3.11 $ Q1
Net Margin Per Quarter (%)
2024: Q4 · 0.7 % Q4 2025: Q1 · 2.8 % Q1 2025: Q2 · -0.5 % Q2 2025: Q3 · -13.3 % Q3 2025: Q4 · -2.2 % Q4 2026: Q1 · 3.1 % Q1
Operating Cash Flow Per Quarter ($M)
2024: Q4 · -587.0 Mio. $ Q4 2025: Q1 · 1,510.0 Mio. $ Q1 2025: Q2 · 1,785.0 Mio. $ Q2 2025: Q3 · 1,356.0 Mio. $ Q3 2025: Q4 · 437.0 Mio. $ Q4 2026: Q1 · 3,600.0 Mio. $ Q1
Free Cash Flow Per Quarter ($M)
2024: Q4 · -741.0 Mio. $ Q4 2025: Q1 · 1,375.0 Mio. $ Q1 2025: Q2 · 1,577.0 Mio. $ Q2 2025: Q3 · 1,145.0 Mio. $ Q3 2025: Q4 · 224.0 Mio. $ Q4 2026: Q1 · 3,400.0 Mio. $ Q1
Sales Growth vs. Year-Ago Quarter (%)
2024: Q4 · 3.4 % Q4 2025: Q1 · 15.4 % Q1 2025: Q2 · 22.4 % Q2 2025: Q3 · 18.2 % Q3 2025: Q4 · 21.9 % Q4 2026: Q1 · 7.1 % Q1
EPS Growth vs. Year-Ago Quarter (%)
2024: Q4 · 573.5 % Q4 2025: Q1 · 21.7 % Q1 2025: Q2 · -123.7 % Q2 2025: Q3 · -1,091.4 % Q3 2025: Q4 · -497.3 % Q4 2026: Q1 · 18.2 % Q1
Price Change in Quarter (%)
2024: Q4 · -19.5 % Q4 2025: Q1 · 0.2 % Q1 2025: Q2 · -10.6 % Q2 2025: Q3 · -34.3 % Q3 2025: Q4 · 15.3 % Q4 2026: Q1 · -20.4 % Q1

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 0.56 573.50 40,805 3.40 0.70 -587 -741
2025: Q1 2.63 21.70 46,620 15.40 2.80 1,510 1,375
2025: Q2 -0.51 -123.70 48,742 22.40 -0.50 1,785 1,577
2025: Q3 -13.50 -1,091.40 49,690 18.20 -13.30 1,356 1,145
2025: Q4 -2.24 -497.30 49,725 21.90 -2.20 437 224
2026: Q1 3.11 18.20 49,944 7.10 3.10 3,600 3,400
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

About the Company

Centene Corporation ist ein Managed-Care-Unternehmen, das Programme und Dienste für unterversicherte Familien und gewerbliche Organisationen in den USA anbietet. Es ist in vier Segmenten tätig: Medicaid, Medicare, Commercial und Other.

CEO Insider Trades (12 Mo.)buying own stock
Employees61,000
HeadquartersSaint Louis, MO
Websitecentene.com
IPO Date13. Dec 2001
Next Earnings28. Jul 2026

Management

Management
Name Title Birth Year
Sarah M. London CEO & Director 1981
Andrew Lynn Asher Executive VP & CFO 1969
Susan R. Smith Chief Operating Officer 1976
Christopher Andrew Koster Executive VP, General Counsel & Secretary 1965
Tanya M. McNally Senior VP & Chief People Officer 1974
Theodore Pienkos Corporate Controller & Chief Accounting Officer 1982
Brian Phillip LeClaire M.B.A., Ph.D. Chief Information Officer 1960
Jennifer Lynch Gilligan Senior Vice President of Investor Relations
Ashlee Knuckey Chief Risk, Ethics & Compliance Officer
Cary D. Hobbs Executive VP & Chief of Staff 1968

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 20, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?